4th Quarter - Amendment

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$1,730,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2012 $1,700,000 Replaced
4th Quarter - Amendment (this page) May 25, 2012 $1,730,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Repatriation Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box H.R. 2735, CFC Look Through Permanency H.R. 1834, Freedom to Invest Act H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) S. 1671, The Foreign Earnings Reinvestment Act S. 1346, the Stop Tax Haven Abuse Act

LobbyistCovered position, as disclosed
MARIA CINO —
KEN W COLE —
CAROLINE MOODY SCHELLHAS —

Contacted: State, Dept of (DOS); Patent & Trademark Office (PTO); Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC)

Bills named: H.R. 2735 (112th), S. 1671 (112th), H.R. 2495 (112th), S. 1346 (112th), H.R. 1834 (112th)

Copyright/Patent/Trademark CPT

Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act

LobbyistCovered position, as disclosed
KEN W COLE —
JENNIFER DUCK —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); State, Dept of (DOS); SENATE; Commerce, Dept of (DOC); Food & Drug Administration (FDA)

Health Issues HCR

Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011

Contacted: Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: S. 668 (112th), S. 1599 (112th), H.R. 452 (112th), H.R. 979 (112th), H.R. 965 (112th)

Consumer Issues/Safety/Products CSP

Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction The Food, Drug and Cosmetic Globalization Act ELDU Ban on Cephalosporin PSE Issues OTC Products in Flexible Spending Account Supply Chain Issues Counterfeits

LobbyistCovered position, as disclosed
KEN W COLE —
JENNIFER DUCK —
JOHN PAUL HALLIWELL —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); SENATE

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation

LobbyistCovered position, as disclosed
KEN W COLE —
JENNIFER DUCK —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); State, Dept of (DOS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Patent & Trademark Office (PTO)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.